STX1A
Syntaxin-1A
Also known as: HPC-1, p35-1, STX1, STX1A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16623
- Gene
- STX1A
- Ensembl
- ENSG00000106089
- Chromosome
- 7
- Canonical length
- 288 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Nuclear membrane,Vesicles
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a member of the syntaxin superfamily. Syntaxins are nervous system-specific proteins implicated in the docking of synaptic vesicles with the presynaptic plasma membrane. Syntaxins possess a single C-terminal transmembrane domain, a SNARE [Soluble NSF (N-ethylmaleimide-sensitive fusion protein)-Attachment protein REceptor] domain (known as H3), and an N-terminal regulatory domain (Habc). Syntaxins bind synaptotagmin in a calcium-dependent fashion and interact with voltage dependent calcium and potassium channels via the C-terminal H3 domain. This gene product is a key molecule in ion channel regulation and synaptic exocytosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
288 residues, UniProt reviewed canonical sequence.
>Q16623|STX1A
1 MKDRTQELRT AKDSDDDDDV AVTVDRDRFM DEFFEQVEEI RGFIDKIAEN VEEVKRKHSA
61 ILASPNPDEK TKEELEELMS DIKKTANKVR SKLKSIEQSI EQEEGLNRSS ADLRIRKTQH
121 STLSRKFVEV MSEYNATQSD YRERCKGRIQ RQLEITGRTT TSEELEDMLE SGNPAIFASG
181 IIMDSSISKQ ALSEIETRHS EIIKLENSIR ELHDMFMDMA MLVESQGEMI DRIEYNVEHA
241 VDYVERAVSD TKKAVKYQSK ARRKKIMIII CCVILGIVIA STVGGIFALocalizationUniProt · AlphaFold · HPA
Whether an antibody against STX1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 170 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 170 nTPM
- cerebellum: 110 nTPM
- pituitary gland: 94 nTPM
- amygdala: 86 nTPM
- hippocampal formation: 69 nTPM
- hypothalamus: 25 nTPM
Single-cell type
- pancreatic islet cells: 94 nCPM
- platelets: 93 nCPM
- brain excitatory neurons: 48 nCPM
- neuroendocrine cells: 44 nCPM
- lactotrophs: 38 nCPM
- somatotrophs: 34 nCPM
Immune cell
- total PBMC: 0.7 nTPM
- gdT-cell: 0.6 nTPM
- T-reg: 0.6 nTPM
- MAIT T-cell: 0.2 nTPM
- naive CD4 T-cell: 0.2 nTPM
- memory B-cell: 0.1 nTPM
Brain region
- cerebral cortex: 137 nTPM
- basal ganglia: 105 nTPM
- white matter: 92 nTPM
- hippocampal formation: 74 nTPM
- amygdala: 69 nTPM
- cerebellum: 37 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about STX1A.
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 55 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.29
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 2.4
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium-ion regulated exocytosis
- exocytosis
- insulin secretion
- intracellular protein transport
- positive regulation of calcium ion-dependent exocytosis
- positive regulation of catecholamine secretion
- positive regulation of excitatory postsynaptic potential
- positive regulation of neurotransmitter secretion
- positive regulation of norepinephrine secretion
- protein localization to membrane
- protein sumoylation
- regulation of insulin secretion
- regulation of synaptic vesicle priming
- response to gravity
- secretion by cell
- SNARE complex assembly
- synaptic vesicle docking
- synaptic vesicle endocytosis
- synaptic vesicle exocytosis
- vesicle docking
- vesicle fusion
Molecular functions
- ATP-dependent protein binding
- calcium channel inhibitor activity
- calcium-dependent protein binding
- chloride channel inhibitor activity
- identical protein binding
- kinase binding
- myosin head/neck binding
- protein-containing complex binding
- SNAP receptor activity
- SNARE binding
- transmembrane transporter binding
Cellular components
- actomyosin
- axon
- cytosol
- endomembrane system
- extracellular region
- glutamatergic synapse
- neuron projection
- nuclear membrane
- plasma membrane
- postsynaptic density membrane
- presynaptic active zone membrane
- Schaffer collateral - CA1 synapse
- secretory granule
- SNARE complex
- synaptic vesicle membrane
- synaptobrevin 2-SNAP-25-syntaxin-1a complex
- synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex
- synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex
- voltage-gated potassium channel complex
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STX1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STX1A as an antibody target. Whether an autoantibody or antibody against STX1A could matter depends on whether native STX1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STX1A is annotated at the cell surface, where native STX1A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label STX1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...